Nesher Technologies (NTI) is a Los Angeles-based company that aims to revolutionize healthcare by developing sensitive and cost-effective diagnostic tools. They specialize in the patented Alternating Laser EXcitation (ALEX) technology, which allows for ultrasensitive and highly multiplexed detection and quantification of target molecules in complex samples. NTI's innovative platform has potential applications in various fields, including early cancer detection, neurodegenerative diseases, drug discovery, and more.
With an exclusive license for the ALEX technology, NTI is focused on commercializing automated diagnostic tests that can detect multiple biomarkers, pathogens, and genetic aberrations simultaneously. Their research-grade prototype, the four-color ALEX single molecule fluorescence spectroscopy instrumentation, has already garnered attention in academia and received small business grants from the National Institutes of Health. NTI's mission is to empower clinicians and researchers with advanced analytical and diagnostic systems, ultimately improving disease detection and treatment outcomes.
Generated from the website
